Patent details

EP1660458 Title: 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1660458
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP04764093.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
13/08/2004
Grant date:
25/01/2012
EP Publication Date:
25/01/2012
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/01/2012
EP B1 Publication Date:
25/01/2012
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
11/04/2012
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/08/2024
Lapsed By Expiration Date:
13/08/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
24/12/2015
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Historical Applicant/holder

From:
24/12/2015
To:
24/12/2015

 

Name:
Novartis International Pharmaceutical Ltd.
Address:
131 Front Street, HM 12, Hamilton, Bermuda (BM)

From:
24/12/2015
To:
24/12/2015

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

From:
25/01/2012
To:
24/12/2015

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

From:
25/01/2012
To:
24/12/2015

 

Name:
IRM LLC
Address:
131 Front Street P.O. Box HM 2899, HAMILTON HM LX, Bermuda (BM)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
25/01/2012
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
GARCIA-ECHEVERRIA, Carlos
Address:
CH-4052 BASEL, Switzerland (CH)

2

Name:
KANAZAWA, Takanori
Address:
TSUKUBA-SHI, IBARAKI PREF. 305-0033, Japan (JP)

3

Name:
KAWAHARA, Eiji
Address:
TSUKUBA-SHI, IBARAKI PREF. 305-0061, Japan (JP)

4

Name:
MASUYA, Keiichi
Address:
TSUKUBA-SHI, IBARAKI PREF. 300-3257, Japan (JP)

5

Name:
MATSUURA, Naoko
Address:
TSUKUBA-SHI, IBARAKI PREF. 305-0005, Japan (JP)

6

Name:
MIYAKE, Takahiro
Address:
TSUKUBA-SHI, IBARAKI PREF. 305-0005, Japan (JP)

7

Name:
OHMORI, Osamu
Address:
TSUKUBA-SHI, IBARAKI PREF. 305-0047, Japan (JP)

8

Name:
UMEMURA, Ichiro
Address:
TSUKUBA-SHI, IBARAKI PREF. 305-0051, Japan (JP)

9

Name:
STEENSMA, Ruo
Address:
LA JOLLA, CA 92037, United States of America (US)

10

Name:
CHOPIUK, Greg
Address:
SAN DIEGO, CA 92130, United States of America (US)

11

Name:
JIANG, Jiqing
Address:
SAN DIEGO, CA 92122, United States of America (US)

12

Name:
WAN, Yongqin
Address:
SAN DIEGO, CA 92122, United States of America (US)

13

Name:
DING, Qiang
Address:
SAN DIEGO, CA 92122, United States of America (US)

14

Name:
ZHANG, Qiong
Address:
SAN DIEGO, CA 92122, United States of America (US)

15

Name:
GRAY, Nathanael, Schiander
Address:
SAN DIEGO, CA 92122, United States of America (US)

16

Name:
KARANEWSKY, Donald
Address:
ESCONDIDO, CA 92029, United States of America (US)

Priority

1

Priority Patent Number:
0322370
Priority Date:
24/09/2003
Priority Country:
United Kingdom (GB)

2

Priority Patent Number:
0319227
Priority Date:
15/08/2003
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 239/48;
IPC or IDT classification:
A61K 31/506; A61K 35/00; A61P 29/00; A61P 37/00; C07D 401/12; C07D 401/14; C07D 403/12; C07D 405/12;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
33/24
Publication date:
14/08/2024
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
17/16
Publication date:
28/04/2016
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
17/16
Publication date:
28/04/2016
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
EP3
Journal edition number:
2012/17
Publication date:
25/04/2012
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
2012/05
Publication date:
01/02/2012
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201204
Publication date:
25/01/2012
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC201600729B
Date Registered:
24/12/2015
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Dennemeyer & Associates
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

2

Name:
Novartis International Pharmaceutical Ltd.
Address:
131 Front Street, HM 12, Hamilton, Bermuda (BM)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201600729D
Date Registered:
24/12/2015
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Dennemeyer & Associates
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
28/07/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
24/12/2015 RFC Correspondence Accompanying letter deed 3 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_0_rfc20160420022719226.pdf
24/12/2015 RFC Correspondence Accompanying letter deed 2 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_1_rfc20160421125458132.pdf
24/12/2015 RFC Correspondence Accompanying letter deed 2 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_5_rfc20160420022654138.pdf
11/04/2012 Claims Translated claims 4 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_2_claims20120411.pdf
11/04/2012 Description Translated description 267 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_3_description20120411.pdf
11/04/2012 Outgoing Correspondence Outgoing Letter 1 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_4_outgoingcorrespondence20120411.pdf
11/04/2012 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_7_incomingcorrespondencepaper20120411.pdf
02/03/2012 Incoming Correspondence Paper Correspondence address details 1 PDF /3/9/0/4/6/0504764093/docs/ep04764093.3_6_incomingcorrespondencepaper20120302.pdf